Cargando…
Incidental benefits after fecal microbiota transplant for ulcerative colitis
Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like metabolic syndrome and functional ga...
Autores principales: | Mahajan, Ramit, Midha, Vandana, Singh, Arshdeep, Mehta, Varun, Gupta, Yogesh, Kaur, Kirandeep, Sudhakar, Ritu, Singh Pannu, Anmol, Singh, Dharmatma, Sood, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385574/ https://www.ncbi.nlm.nih.gov/pubmed/32306706 http://dx.doi.org/10.5217/ir.2019.00108 |
Ejemplares similares
-
Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
por: Midha, Vandana, et al.
Publicado: (2018) -
Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
por: Sood, Ajit, et al.
Publicado: (2022) -
Trends of inflammatory bowel disease at a tertiary care center in northern India
por: Sood, Ajit, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
por: Sood, Ajit, et al.
Publicado: (2020) -
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
por: Sood, Ajit, et al.
Publicado: (2019)